Can dysglycemia in OGTT be predicted by baseline parameters in patients with PCOS?
Sarantis LivadasChristina BothouJustyna Kuliczkowska-PłaksejRalitsa RobevaAndromahi VryonidouJelica Bjekic MacutIoannis AndroulakisMilica OpalicZadalla MouslechAndrej MilewiczAlessandra GambineriDimitrios PanidisDjuro MacutPublished in: Endocrine connections (2022)
One-third of our cohort of PCOS women with either T2DM or IGT displayed normal fasting glucose values but without confirming any specific predictor for dysglycemic condition. Hence, the evaluation of glycemic status using OGTT in all women with PCOS is strongly supported.